Using Genetics in Mainstream Medicine to Deliver Personalised Care for Cancer Patients.

Sarah Darby

Assessment of the benefits and risks of cancer treatments

Breast

Pediatric oncology or childhood cancer Radiation Oncology

Darren Patten

Understanding the effects of aromatase inhibition on oestrogen receptor and co-factor binding in primary breast cancer

Breast

Laura Kenny

Molecular imaging of HER2 receptor expression using PET: mechanistic study of the novel [18F]-HER2-Affibody tracer in metastatic breast cancer

Breast

Victoria Harding

The role of miRNAs in regulation and signalling induced by a new oncogenic kinase, LMTK3

Breast

Georgios Giamas

Compound Screening for the Identification of LMTK3 Kinase-Inhibitors

Breast

Bianca De Stavola

Newton001-Developing tools to study inequalities in women's access to breast and cervical cancer control activities in Brazil using health-related DB

Breast

Waljit Dhillo

MICA: Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes

Breast

Ben O'Leary

MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies

Breast

Pathology

Corey Casper

Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)

Non-Hodgkin lymphoma Kaposi sarcoma Hodgkin lymphoma Cervix uteri Breast